Inventor · disambiguated record
Gaetan Ladouceur
Also filed as: LADOUCEUR GAETAN · LADOUCEUR GAETAN H
28 granted patents·13 pending applications·559 citations·filing 1993–2010
96Inventor score
Files withBAYER PHARMACEUTICALS CORP17BAYER AG10BAYER HEALTHCARE LLC4AGOSTON GREGORY E1LADOUCEUR GAETAN1
Top patents by PatentIndex Score
41 records- 0194US7838524B2Substituted pyrazolyl urea derivatives useful in the treatment of cancerBAYER HEALTHCARE LLC·Filed 2005·Granted Nov 23, 2010·50 cites·37 claims
- 0292US5939462ANPY5 receptor antagonists and methods for using sameBAYER AG·Filed 1998·Granted Aug 17, 1999·117 cites·15 claims
- 0391US8207166B2Substituted pyrazolyl urea derivatives useful in the treatment of cancerLEE WENDY·Filed 2010·Granted Jun 26, 2012·24 cites·6 claims
- 0488US6218431B1Substituted biphenylsBAYER AG·Filed 1997·Granted Apr 17, 2001·93 cites·6 claims
- 0586US6660752B22,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 9, 2003·24 cites·30 claims
- 0686US5409932APiperazine-substituted pyrroloanthracenesBAYER AG·Filed 1993·Granted Apr 25, 1995·34 cites·11 claims
- 0784US5411960ASubstituted pyrroloanthracenes and -dionesBAYER AG·Filed 1993·Granted May 2, 1995·29 cites·5 claims
- 0881US6410792B1Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonistsBAYER AG·Filed 1999·Granted Jun 25, 2002·55 cites·8 claims
- 0980US7585888B2Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2008·Granted Sep 8, 2009·4 cites·5 claims
- 1079US7384947B2Fused tricyclic heterocycles useful for treating hyper-proliferative disordersBAYER HEALTHCARE LLC·Filed 2006·Granted Jun 10, 2008·2 cites·5 claims
- 1177US6048900AAmide derivatives and methods for using the same as selective neuropeptide Y receptor antagonistsBAYER AG·Filed 1998·Granted Apr 11, 2000·41 cites·13 claims
- 1274US6245817B1NPY5 receptor antagonists and methods for using sameBAYER AG·Filed 1999·Granted Jun 12, 2001·46 cites·9 claims
- 1372US6699860B2Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Mar 2, 2004·8 cites·20 claims
- 1471US6051586ASulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonistsBAYER AG·Filed 1998·Granted Apr 18, 2000·12 cites·11 claims
- 1570US7144885B2Fused tricyclic heterocycles useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Dec 5, 2006·4 cites·26 claims
- 1669US8796250B2Diaryl ureas for diseases mediated by PDGFRWILHELM SCOTT·Filed 2004·Granted Aug 5, 2014·5 cites·55 claims
- 1769US7803956B2Benzofuran derivatives useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2009·Granted Sep 28, 2010·0 cites·19 claims
- 1867US7659412B2Benzofuran derivatives useful for treating hyper-proliferative disordersBAYER HEALTHCARE LLC·Filed 2008·Granted Feb 9, 2010·0 cites·8 claims
- 1967US7351735B2Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Apr 1, 2008·3 cites·21 claims
- 2067US6780859B2Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Aug 24, 2004·3 cites·16 claims
- 2166US6919371B22,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Jul 19, 2005·2 cites·24 claims
- 2259US2009143412A1Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disordersBAYER HEALTHCARE LLC·Filed 2008·Application pending·0 cites
- 2354US7420066B2Benzofuran derivatives useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 2, 2008·0 cites·7 claims
- 2453US2005215594A12,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
- 2552US7429584B2Furo[2.3-b]pyridine derivatives for the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Sep 30, 2008·0 cites·10 claims
- 2652US6903218B2Sulfonamide substituted chroman derivativesBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Jun 7, 2005·0 cites·5 claims
- 2750US2011318393A1Substituted Pyrazole CompoundsLADOUCEUR GAETAN·Filed 2009·Application pending·0 cites
- 2846US7238701B2Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Jul 3, 2007·0 cites·7 claims
- 2946US2006063760A1Hydroxamic acids useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Application pending·0 cites
- 3045US2011195110A1Urea compounds useful in the treatment of cancerSMITH ROGER·Filed 2006·Application pending·0 cites
- 3145US2003073839A1Compounds useful for preparation of Beta-3 adrenoreceptor agonistFiled 2000·Application pending·0 cites
- 3244US2007105851A1Indolyl-thienopyrazinone derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesisBAYER PHARMACEUTICALS CORP·Filed 2004·Application pending·0 cites
- 3343US2006004011A1Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER PHARMACEUTICALS CORP·Filed 2003·Application pending·0 cites
- 3442US8501755B2Tetrahydropyridothienopyrimidine compounds and methods of use thereofZHANG CHENGZHI·Filed 2007·Granted Aug 6, 2013·0 cites·21 claims
- 3541US2009029992A1Substituted pyrazole compoundsAGOSTON GREGORY E·Filed 2008·Application pending·0 cites
- 3641US2005119246A11H-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptorBAYER PHARMACEUTICALS CORP·Filed 2002·Application pending·0 cites
- 3740US2005119489A14-Sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptorFiled 2002·Application pending·0 cites
- 3840US2004236110A1Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitorsFiled 2002·Application pending·0 cites
- 3938US5461054AAnthracene-spiro-pyrrolindinesBAYER AG·Filed 1993·Granted Oct 24, 1995·3 cites·5 claims
- 4037US2004267017A13-pyridyl or 4-isoquinolinyl thiazoles as c17, 20 lyase inhibitorsFiled 2002·Application pending·0 cites
- 4131US5459143AN,N-disubstituted piperazinesBAYER AG·Filed 1993·Granted Oct 17, 1995·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →